Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential

Diabetes. 2010 Sep;59(9):2087-93. doi: 10.2337/db10-0630.

Authors

Mark Peakman¹, Matthias von Herrath

Affiliation

¹ Department of Immunobiology, National Institute for Health Research, Comprehensive Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust, King's College London, London, UK. mark.peakman@kcl.ac.uk

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antigens / immunology*
Antigens / therapeutic use*
Autoimmune Diseases / immunology
Biomedical Research
Clinical Trials as Topic
Dendritic Cells / immunology
Diabetes Mellitus, Type 1 / immunology*
Diabetes Mellitus, Type 1 / pathology
Epitopes / immunology
Humans
Immunotherapy / methods*
Insulin-Secreting Cells / pathology

Substances

Antigens
Epitopes